INFLECTION POINT ACQUISITION CORP. IV

For the period ended Sep 30, 2025. Filed Nov 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 12, 2025

MRLN$0.99+14.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Report.

No.	Description of Exhibit
1.1	Amendment to Underwriting Agreement, dated August 5, 2025, by and between the Company and Cohen & Company Capital Markets, a division of J.V.B Financial Group, LLC, as representative of the several underwriters (incorporated by reference to Exhibit 1.1 of the Company’s Form 10-Q filed with the Commission on August 8, 2025).
2.1†	Business Combination Agreement, dated as of August 13, 2025, by and among Inflection Point Acquisition Corp. IV, IPDX Merger Sub, Inc. and Merlin Labs, Inc (incorporated by reference to Exhibit 2.1 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
3.1	Form of Certificate of Designation relating to the 12.0% Series A Cumulative Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
4.1	Form of Warrant to be issued to each Series A Preferred Stock Investor (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.1	Sponsor Support Agreement, dated August 13, 2025, by and among Bleichroeder Sponsor 1 LLC, Inflection Point Fund I, LP, Bleichroeder Acquisition Corp. I and Merlin Labs, Inc. (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.2	Form of Stockholder Voting and Support Agreement (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.3	Form of Sponsor Lock-Up Agreement (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.4	Form of Merlin Labs Lock-Up Agreement (incorporated by reference to Exhibit 10.4 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.5	Form of Amended and Restated Registration Rights Agreement (incorporated by reference to Exhibit 10.5 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.6	Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K filed with the Commission on August 14, 2025).
10.7	Consulting Agreement, dated July 28, 2025, by and between the Company and the Consultant (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed with the Commission on July 31, 2025)
31.1*	Certification of the Principal Executive Officer Pursuant to Rules 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of the Principal Financial Officer Pursuant to Rules 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**	Certification of the Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**	Certification of the Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	Inline XBRL Instance Document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.
**	Furnished herewith.
†	Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.